Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.44) by ($0.01), Briefing.com reports. The firm had revenue of $0.48 million for the quarter, compared to the consensus estimate of $1.44 million. During […]
Profund Advisors LLC Purchases 59,427 Shares of Iovance Biotherapeutics, Inc (NASDAQ:IOVA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) had its price objective upped by Wells Fargo & Company from $17.00 to $22.00 in a research report released on Tuesday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the biotechnology company’s stock. Other research analysts have also issued research reports about the stock. […]
Iovance Biotherapeutics (NASDAQ:IOVA) Hits New 52-Week High at $16 93 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Iovance Biotherapeutics (NASDAQ:IOVA) PT Raised to $19 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.